Columbia University

Technology Ventures

Pfizer’s Centers for Therapeutic Innovation Requests Proposals for Therapeutic Targets (Large Molecule Programs Only)

Monday, June 21, 2021 - 5:00pm

Pfizer’s Centers for Therapeutic Innovation (CTI) requests proposals for novel therapeutic targets with application across Pfizer's core therapeutic areas:

  • Oncology
    • Tumor targeted
    • Immuno-Oncology
    • Cancer vaccines
  • Internal medicine
    • Obesity/cachexia
    • Heart failure
    • Diabetic/chronics kidney disease
    • NASH/T2D
  • Inflammation & immunology
    • Rheumatology
    • Gastroenterology
    • Medical derm
  • Rare disease
    • Cardiology
    • Neuro-musc.
    • Metabolic
    • Hematology

Collaboration with CTI provides access to Pfizer R&D strengths, resources, and capabilities to help guide and advance novel scientific approaches.

  • Each investigator is paired with a scientific champion at Pfizer
  • Funding is provided for project-specific research in the academic lab
  • Complementary biology and drug discovery are performed at Pfizer

Submission process:

  • Develop a 2-3 page non-confidential document outlining the scientific background and research synopsis
  • Faculty interested in submitting a project should contact [email protected]. Pre-proposals should be reviewed by one of Pfizer’s Emerging Science Leads to determine suitability prior to submission. Formal submission should be routed through Columbia Technology Ventures.
  • The deadline to submit pre-proposals to Columbia Technology Ventures is June 21, 2021.
  • Please see the Related Documents section of this page for additional information.